Search

Your search keyword '"Aaron G. Schmidt"' showing total 108 results

Search Constraints

Start Over You searched for: Author "Aaron G. Schmidt" Remove constraint Author: "Aaron G. Schmidt"
108 results on '"Aaron G. Schmidt"'

Search Results

1. Bat humoral immunity and its role in viral pathogenesis, transmission, and zoonosis

2. B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S

3. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds

4. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

5. Mechanisms that promote the evolution of cross-reactive antibodies upon vaccination with designed influenza immunogens

6. Protein engineering strategies for rational immunogen design

7. Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization

8. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV‑2

9. Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

10. Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting

11. Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization

12. Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site

13. Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2

14. A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters

15. Invasion of the germinal centers

16. Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody

18. An epitope-enriched immunogen increases site targeting in germinal centers

19. SARS-CoV-2 Serosurveys: How antigen, isotype and threshold choices affect the outcome

20. Rotavirus VP4 Epitope of a Broadly Neutralizing Human Antibody Defined by Its Structure Bound with an Attenuated-Strain Virion

21. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses

22. An epitope-enriched immunogen expands responses to a conserved viral site

23. High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts

24. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

25. Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques

26. Structure-Guided Molecular Grafting of a Complex Broadly Neutralizing Viral Epitope

27. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

28. Preferential expansion upon boosting of cross-reactive 'pre-existing' switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein

29. Affinity maturation in a human humoral response to influenza hemagglutinin

30. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells

31. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

32. Homologous and Heterologous Vaccine Boost Strategies for Humoral and Cellular Immunologic Coverage of the SARS-CoV-2 Omicron Variant

33. Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design

34. Early cross-coronavirus reactive signatures of humoral immunity against COVID-19

35. An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice

37. Durability of Heterologous and Homologous COVID-19 Vaccine Boosts

38. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

39. Sequential conformational rearrangements in flavivirus membrane fusion

40. Rapid generation of potent antibodies by autonomous hypermutation in yeast

41. Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19

42. Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity

43. Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection

44. The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection

45. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif

46. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike

47. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

48. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses

49. Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

50. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

Catalog

Books, media, physical & digital resources